Subtopic Deep Dive
Sphingosine Kinase Regulation
Research Guide
What is Sphingosine Kinase Regulation?
Sphingosine Kinase Regulation studies the activation, post-translational modifications, and pharmacological inhibition of sphingosine kinase isoforms (SphK1 and SphK2) that phosphorylate sphingosine to produce bioactive sphingosine-1-phosphate (S1P).
SphK1 and SphK2 catalyze S1P formation, central to sphingolipid signaling in inflammation and cancer. Regulation occurs via phosphorylation, translocation, and GPCR agonists. Over 10 papers from 1998-2017 detail these mechanisms, with Maceyka & Spiegel (2014) citing 1231 times.
Why It Matters
SphK regulation identifies drug targets in cancer and inflammation, as S1P promotes cell survival and proliferation (Öğretmen & Hannun, 2004; 1200 citations). Inhibitors block tumor growth, with clinical potential shown in sphingolipid pathway modulation (Wymann & Schneiter, 2008; 1259 citations). Maceyka & Spiegel (2014; 1231 citations) link SphK1 upregulation to inflammatory diseases, enabling targeted therapies.
Key Research Challenges
Isoform-Specific Regulation
Distinguishing SphK1 vs SphK2 activation remains difficult due to overlapping substrates and localizations. Pyne & Pyne (2000; 695 citations) note differential responses to stimuli like growth factors. Selective inhibitors are needed for precise targeting.
Post-Translational Controls
Phosphorylation and lipid rafts modulate SphK activity, but mechanisms are incompletely mapped. Płóciennikowska et al. (2014; 735 citations) highlight raft proteins in signaling. Quantifying these dynamics challenges drug design.
Therapeutic Inhibitor Development
SphK inhibitors face off-target effects in cancer therapy. Öğretmen (2017; 1154 citations) reviews pathway dysregulation. Balancing efficacy and specificity hinders clinical translation.
Essential Papers
Lipid signalling in disease
Matthias P. Wymann, Roger Schneiter · 2008 · Nature Reviews Molecular Cell Biology · 1.3K citations
Sphingolipid metabolites in inflammatory disease
Michael Maceyka, Sarah Spiegel · 2014 · Nature · 1.2K citations
Biologically active sphingolipids in cancer pathogenesis and treatment
Besim Öğretmen, Yusuf A. Hannun · 2004 · Nature reviews. Cancer · 1.2K citations
Sphingolipid metabolism in cancer signalling and therapy
Besim Öğretmen · 2017 · Nature reviews. Cancer · 1.2K citations
Edg-1, the G protein–coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
Yujing Liu, Ryuichi Wada, Tadashi Yamashita et al. · 2000 · Journal of Clinical Investigation · 1.1K citations
Sphingolipid signaling pathways have been implicated in many critical cellular events. Sphingosine-1-phosphate (SPP), a sphingolipid metabolite found in high concentrations in platelets and blood, ...
The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind
Yusuf A. Hannun, Lina M. Obeid · 2002 · Journal of Biological Chemistry · 902 citations
sphingosine 1-phosphate sphingomyelin sphingomyelinase ceramidase tumor necrosis factor glucosylceramide synthase serine palmitoyltransferase protein kinase C interleukin-1 diacylglycerol neutral s...
The Kennedy pathway—<i>De novo</i> synthesis of phosphatidylethanolamine and phosphatidylcholine
Federica Gibellini, Terry Smith · 2010 · IUBMB Life · 781 citations
Abstract The glycerophospholipids phosphatidylcholine (PC) and phosphatidylethanolamine (PE) account for greater than 50% of the total phospholipid species in eukaryotic membranes and thus play maj...
Reading Guide
Foundational Papers
Start with Maceyka & Spiegel (2014; 1231 citations) for inflammatory roles and Pyne & Pyne (2000; 695 citations) for core signaling mechanisms, as they establish SphK activation basics.
Recent Advances
Study Öğretmen (2017; 1154 citations) for cancer therapy advances and its integration with earlier works like Öğretmen & Hannun (2004).
Core Methods
Core techniques: kinase assays for S1P production, lipid raft isolation (Płóciennikowska et al., 2014), and GPCR stimulation (Liu et al., 2000).
How PapersFlow Helps You Research Sphingosine Kinase Regulation
Discover & Search
Research Agent uses searchPapers with 'sphingosine kinase regulation SphK1 SphK2 inhibitors' to retrieve Maceyka & Spiegel (2014; 1231 citations), then citationGraph reveals connections to Pyne & Pyne (2000; 695 citations), and findSimilarPapers expands to 50+ related works on isoform regulation.
Analyze & Verify
Analysis Agent applies readPaperContent on Öğretmen & Hannun (2004) to extract SphK activation data, verifyResponse with CoVe checks claims against 10 papers for consistency, and runPythonAnalysis plots S1P signaling pathways with matplotlib; GRADE scores evidence strength for inhibitor efficacy claims.
Synthesize & Write
Synthesis Agent detects gaps in isoform-specific inhibitors via contradiction flagging across Wymann & Schneiter (2008) and Öğretmen (2017), while Writing Agent uses latexEditText for pathway diagrams, latexSyncCitations to integrate 20 references, and latexCompile for publication-ready reviews.
Use Cases
"Analyze S1P production rates from SphK1/2 in cancer datasets"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on extracted kinase data) → statistical plots of regulation kinetics and GRADE-verified significance.
"Draft review on SphK inhibitors with figures and citations"
Synthesis Agent → gap detection → Writing Agent → latexEditText (pathway edits) → latexSyncCitations (Öğretmen 2017 et al.) → latexCompile → PDF with S1P signaling mermaid diagram.
"Find code for sphingosine kinase simulation models"
Research Agent → paperExtractUrls (Hannun & Obeid 2002) → paperFindGithubRepo → githubRepoInspect → runnable Python models for lipid signaling dynamics.
Automated Workflows
Deep Research workflow scans 50+ papers on SphK regulation, chaining searchPapers → citationGraph → structured report with GRADE scores on inhibitor trials. DeepScan applies 7-step analysis with CoVe checkpoints to verify claims from Maceyka & Spiegel (2014). Theorizer generates hypotheses on raft-mediated SphK activation from Pyne & Pyne (2000).
Frequently Asked Questions
What defines Sphingosine Kinase Regulation?
It examines activation and inhibition of SphK1/SphK2 enzymes producing S1P, key in sphingolipid signaling (Pyne & Pyne, 2000).
What are main regulation methods?
Methods include phosphorylation, GPCR agonists, and lipid raft localization, as detailed in Płóciennikowska et al. (2014).
What are key papers?
Top papers: Wymann & Schneiter (2008; 1259 citations), Maceyka & Spiegel (2014; 1231 citations), Öğretmen & Hannun (2004; 1200 citations).
What open problems exist?
Challenges include isoform-selective inhibitors and quantifying post-translational dynamics (Öğretmen, 2017).
Research Sphingolipid Metabolism and Signaling with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Sphingosine Kinase Regulation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers